T6947 |
Piperlongumine
|
20069-09-4
|
99.89%
|
|
Piperlongumine (Piplartine) is a natural alkaloid from Piper longum L. It selectively kills cancer cells and strengthens the level of reactive oxygen species (RO...
|
T5S0168 |
Atractylenolide II
|
73069-14-4
|
99.89%
|
|
1. Atractylenolide II (2-Atractylenolide) has antimelanoma effect by inhibiting STAT3 signalling. 2. Atractylenolide II has cytotoxic/apoptotic effects may via p...
|
T7005 |
Ulixertinib
|
869886-67-9
|
99.89%
|
|
Ulixertinib (VRT752271) (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
|
T3001 |
Honokiol
|
35354-74-6
|
99.87%
|
|
Honokiol (NSC-293100) is the active principle of magnolia extract. It inhibits the activation of Akt and enhances the phosphorylation of ERK1/ERK2.
|
T6511 |
Ravoxertinib
|
1453848-26-4
|
99.87%
|
|
Ravoxertinib (GDC-0994) is an effective and orally available ERK1/2 inhibitor (IC50: 1.1/0.3 nM).
|
T2416 |
BIX02189
|
1094614-85-3
|
99.86%
|
|
BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM.
|
TN2346 |
Mogrol
|
88930-15-8
|
99.85%
|
|
Mogrol, a biometabolite of mogrosides, functions by inhibiting the ERK1/2 and STAT3 pathways, diminishing CREB activation, and activating AMPK signaling.
|
T5727 |
CAFESTOL
|
469-83-0
|
99.84%
|
|
CAFESTOL is a ERK inhibitor for AP-1-targeted activity against PGE2 production and the mRNA expression of cyclooxygenase (COX)-2 in LPS-activated RAW264.7 cells....
|
T10479 |
BAY885
|
2307249-33-6
|
99.83%
|
|
BAY885 is a new ERK5 inhibitor.
|
T1144 |
Lidocaine hydrochloride
|
73-78-9
|
99.83%
|
|
Lidocaine hydrochloride (Lignocaine hydrochloride) is a local anesthetic and cardiac depressant used as an antiarrhythmic agent. Its actions are more intense and...
|
T62929 |
RLX-33
|
2784577-71-3
|
99.82%
|
|
RLX-33 is a potent and selective antagonist of relaxin family peptide 3 (RXFP3) that crosses the blood-brain barrier and also blocks relaxin 3-induced ERK1/2 pho...
|
TN3609 |
Catalposide
|
6736-85-2
|
99.82%
|
|
Catalposide is a potent inducer of (HO)-1 isolated from Catalpa ovate G. Don (Bignoniaceae). Catalposide possesses antioxidant, anti-apoptotic, anti-microbial, a...
|
TN1441 |
Beta-Tocopherol
|
148-03-8
|
99.81%
|
|
Beta-Tocopherol shows effect on human erythroleukemia cell (HEL) adhesion induced by phorbol 12-myristate 13-acetate (PMA).
|
T21588 |
Olomoucine
|
101622-51-9
|
99.8%
|
|
Olomoucine is an ATP competitive inhibitor of Cdk2/cyclin A, Cdc2/CyclinB, CDK2/CyclinE, CDK5/p35, and ERK1/p44 MAP kinase with IC50s of 7, 7, 7, 3 and 25 µM, re...
|
T1956 |
FR 180204
|
865362-74-9
|
99.8%
|
|
FR 180204 is a potent and selective ATP-competitive inhibitor of ERK1 and ERK2.
|
TN1786 |
Isomerazin
|
1088-17-1
|
99.8%
|
|
Isomerazin (Isomeranzin) has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathw...
|
T3844 |
Deltonin
|
55659-75-1
|
99.79%
|
|
Deltonin has an inhibition of ERK1/2 and AKT activation. Deltonin shows cytotoxicity against human HepG2 cells (IC50: 7.66 μM), mouse C26 cells (IC50: 1.22 μM), ...
|
T6993 |
Tauroursodeoxycholate sodium
|
35807-85-3
|
99.78%
|
|
Tauroursodeoxycholate sodium (TUDC) is an endoplasmic reticulum (ER) stress inhibitor, used for the treatment of gallstones and liver cirrhosis.
|
T77734 |
ERK5-IN-5
|
2318792-30-0
|
99.77%
|
|
ERK5-IN-5 is a potent extracellular signal-regulated kinase 5 (ERK5) inhibitor with anticancer activity and potential anticonvulsant activity that inhibits A549 ...
|
T1842 |
XMD17-109
|
1435488-37-1
|
99.75%
|
|
XMD17-109 (ERK5-IN-1) is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
|